Native T1 mapping in transthyretin amyloidosis.
暂无分享,去创建一个
S. K. White | M. Robson | S. Piechnik | J. Moon | P. Hawkins | M. Fontana | S. Castelletti | T. Treibel | D. Sado | V. Maestrini | C. Whelan | S. Banypersad | A. Wechalekar | D. Rowczenio | H. Lachmann | J. Gillmore | J. Gilbertson | D. Hutt | S. Pica | S. White
[1] Chia-Ying Liu,et al. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). , 2013, Journal of the American College of Cardiology.
[2] M. Robson,et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.
[3] A. Petrie,et al. Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome , 2013, Journal of the American Heart Association.
[4] F. Ruberg,et al. T1 mapping in cardiac amyloidosis: can we get there from here? , 2013, JACC. Cardiovascular imaging.
[5] P. Hawkins,et al. Systemic Amyloidosis in England: an epidemiological study , 2013, British journal of haematology.
[6] S. K. White,et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI , 2013, Journal of Cardiovascular Magnetic Resonance.
[7] A. Flett,et al. Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis: An Equilibrium Contrast Cardiovascular Magnetic Resonance Study , 2013, Circulation. Cardiovascular imaging.
[8] Andrew S Flett,et al. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR , 2012, Journal of Cardiovascular Magnetic Resonance.
[9] J. Berk,et al. Transthyretin (TTR) Cardiac Amyloidosis , 2012, Circulation.
[10] F. Salvi,et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. , 2011, JACC. Cardiovascular imaging.
[11] C. Anfuso,et al. MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy. , 2010, AJR. American journal of roentgenology.
[12] R. Falk,et al. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38α MAPK pathway , 2010, Proceedings of the National Academy of Sciences.
[13] E. Nagel,et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[14] Eloisa Arbustini,et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.
[15] P. Lavori,et al. Transthyretin V122I in African Americans with congestive heart failure. , 2006, Journal of the American College of Cardiology.
[16] F. Salvi,et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. , 2005, Journal of the American College of Cardiology.
[17] R. Falk,et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis , 2005, American journal of hematology.
[18] M. Benson,et al. A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population , 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[19] P. Poole‐Wilson,et al. Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2005, Circulation.
[20] R. Falk,et al. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. , 1997, Heart.
[21] J. Buxbaum,et al. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. , 1997, The New England journal of medicine.
[22] R A Kyle,et al. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. , 1983, The American journal of medicine.